News
Novella Clinical Selected by Scioderm to Manage Rare Disease Study
October 15th 2013Novella Clinical, a Quintiles company, is a full service clinical research organization (CRO) and today announced it has been selected by Scioderm to manage a Phase IIb trial for the treatment of Epidermolysis Bullosa (EB),a rare genetic connective tissue condition.
Clinical Conductor Site CTMS Releases Third Major Update of the Year
October 8th 2013The Clinical Conductor Site CTMS development team has just released the third major update of the year. Driven by customer input and a deep understanding of market needs, Clinical Conductor Site has developed a multitude of new features, while enhancing many existing tools.
Future Clinical Trials: How Pharmacies will Transform Clinical Research
October 4th 2013Due to increasing costs and lacking productivity of the existing clinical trial operational model, there has been a lot of awareness around ?Future Clinical Trials,? and some sponsors are seeming to transform pharmacies into study sites.
Clinical Conductor CTMS Collaborates with SCRS to Benchmark Clinical Research Site Metrics
October 3rd 2013Clinical Conductor CTMS?s parent company, Bio-Optronics, Inc., and the Society of Clinical Research Sites (SCRS) have collaborated to expand and advance the knowledge of clinical trial site management challenges and opportunities.
Shutdown Forces FDA, HHS No-Shows
October 3rd 2013Officials from the Food and Drug Administration and the National Institutes of Health were scheduled to explain developments in clinical trial registration and transparency at the Drug Information Association?s conference on Clinical Trial Disclosure in Bethesda, Md. this week.
Patient-Reported Outcomes in Oncology: If No One Pays Attention to Data, Does it Really Exist?
October 2nd 2013In a recent piece published in the New England Journal of Medicine, oncologist Dr. Ethan Basch talks about his perspective that patient-reported outcomes (PROs) are not widely used in the development process for cancer drugs because they are not often measured in clinical trials.
